Moderna has applied to the FDA to permit each vial of Covid-19 vaccine to hold 15 doses, rather than the current labelling of 10 doses. For the media, the public relations statement is that by allowing each vial to hold…
Monthly Archives: January 2021
Moderna (MRNA-$173.16, NASDAQ) Asks FDA to Permit Labelling to Allow for a 15 Dose Per Vial Designation.
Posted in Portfolio Model Subscription
Novavax (NVAX-$218.76, NASDAQ) Covid-19 Vaccine Looks Quite Encouraging: Johnson and Johnson Covid-19 Vaccine (JNJ-$163.55, NYSE), Much Less so.
https://www.barrons.com/articles/novavax-stock-soars-as-its-covid-19-vaccine-outperforms-j-js-51611930639?siteid=yhoof2 Novavax might be a takeover candidate by one of the large pharma companies, based upon this initial indication.
Posted in Portfolio Model Subscription
BJ’s Wholesale Club Holdings (BJ-$49.32, NYSE) Enters into Point of Sale Finance Agreement With Citizens Bank (CFG-$35.27, NYSE).
https://investor.citizensbank.com/about-us/newsroom/latest-news/2021/2021-01-27-120053615.aspx
Posted in Portfolio Model Subscription
“Our Modelling Failed to Anticipate”. Will Vulnerable Commercial Banks Sink the Economy by Acquiring BNPL Lenders?
In 2008, the global economy virtually collapsed due to the sub-prime mortgage crisis, brought on by loose credit policies and the propensity of the public to engage in the acquisition of homes well beyond their debt service capabilities. Sub-prime credit…
Posted in Portfolio Model Subscription
Lack of Efficacy by Sinovac Covid-19 Vaccine Infers that Repression and Innovation ARE Mutually Exclusive.
Q. How Many Nobel Prizes have been awarded since the creation of the Nobel Prize in 1901? A. 919. Q. How many citizens of the Peoples Republic of China, the world’s second largest economy, a nation of 1.439 billion mainland…
Posted in Portfolio Model Subscription